McKenzie, J.
Nisha, P.
Cannon-Bailey, S.
Cain, C.
Kissel, M.
Stachel, J.
Proscyk, C.
Romano, R.
Hardy, B.
Calverley, P. M. A. http://orcid.org/0000-0003-4676-9993
Funding for this research was provided by:
philips respironics
Article History
Received: 10 July 2021
Accepted: 9 December 2021
First Online: 23 December 2021
Declarations
:
: Allendale Institutional Review Board approved the study. All participants gave written, informed consent for the study.
: Not applicable.
: PMAC does not have any directly competing interests but has advised several pharmaceutical companies including GSK, AstraZeneca, Boehringer Ingelheim, Novartis and Recipharm on the conduct and design of clinical trials in COPD. The remaining authors were all employees of Philips Respironics at the time of the conduct of this study.